194 related articles for article (PubMed ID: 36151409)
1. Melatonin relieves hepatic lipid dysmetabolism caused by aging via modifying the secondary bile acid pattern of gut microbes.
Wei D; Li Y; Che M; Li C; Wu Q; Sun C
Cell Mol Life Sci; 2022 Sep; 79(10):527. PubMed ID: 36151409
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol Attenuates Trimethylamine-N-Oxide (TMAO)-Induced Atherosclerosis by Regulating TMAO Synthesis and Bile Acid Metabolism via Remodeling of the Gut Microbiota.
Chen ML; Yi L; Zhang Y; Zhou X; Ran L; Yang J; Zhu JD; Zhang QY; Mi MT
mBio; 2016 Apr; 7(2):e02210-15. PubMed ID: 27048804
[TBL] [Abstract][Full Text] [Related]
3. Chronic sucralose consumption inhibits farnesoid X receptor signaling and perturbs lipid and cholesterol homeostasis in the mouse livers, potentially by altering gut microbiota functions.
Chi L; YifeiYang ; Bian X; Gao B; Tu P; Ru H; Lu K
Sci Total Environ; 2024 Apr; 919():169603. PubMed ID: 38272087
[TBL] [Abstract][Full Text] [Related]
4. Penthorum chinense Pursh. extract attenuates non-alcholic fatty liver disease by regulating gut microbiota and bile acid metabolism in mice.
Li X; Zhao W; Xiao M; Yu L; Chen Q; Hu X; Zhao Y; Xiong L; Chen X; Wang X; Ba Y; Guo Q; Wu X
J Ethnopharmacol; 2022 Aug; 294():115333. PubMed ID: 35500802
[TBL] [Abstract][Full Text] [Related]
5. Trimethylamine N-Oxide Aggravates Liver Steatosis through Modulation of Bile Acid Metabolism and Inhibition of Farnesoid X Receptor Signaling in Nonalcoholic Fatty Liver Disease.
Tan X; Liu Y; Long J; Chen S; Liao G; Wu S; Li C; Wang L; Ling W; Zhu H
Mol Nutr Food Res; 2019 Sep; 63(17):e1900257. PubMed ID: 31095863
[TBL] [Abstract][Full Text] [Related]
6. FXR in the dorsal vagal complex is sufficient and necessary for upper small intestinal microbiome-mediated changes of TCDCA to alter insulin action in rats.
Zhang SY; Li RJW; Lim YM; Batchuluun B; Liu H; Waise TMZ; Lam TKT
Gut; 2021 Sep; 70(9):1675-1683. PubMed ID: 33087489
[TBL] [Abstract][Full Text] [Related]
7. Gut microbiota-associated bile acid deconjugation accelerates hepatic steatosis in ob/ob mice.
Park MY; Kim SJ; Ko EK; Ahn SH; Seo H; Sung MK
J Appl Microbiol; 2016 Sep; 121(3):800-10. PubMed ID: 27111464
[TBL] [Abstract][Full Text] [Related]
8. Cross-talk between bile acids and intestinal microbiota in host metabolism and health.
Nie YF; Hu J; Yan XH
J Zhejiang Univ Sci B; 2015 Jun; 16(6):436-46. PubMed ID: 26055905
[TBL] [Abstract][Full Text] [Related]
9. Dietary lipids, gut microbiota and lipid metabolism.
Schoeler M; Caesar R
Rev Endocr Metab Disord; 2019 Dec; 20(4):461-472. PubMed ID: 31707624
[TBL] [Abstract][Full Text] [Related]
10. Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism.
Pathak P; Xie C; Nichols RG; Ferrell JM; Boehme S; Krausz KW; Patterson AD; Gonzalez FJ; Chiang JYL
Hepatology; 2018 Oct; 68(4):1574-1588. PubMed ID: 29486523
[TBL] [Abstract][Full Text] [Related]
11. Antarctic krill oil ameliorates liver injury in rats exposed to alcohol by regulating bile acids metabolism and gut microbiota.
Guo P; Xue M; Teng X; Wang Y; Ren R; Han J; Zhang H; Tian Y; Liang H
J Nutr Biochem; 2022 Sep; 107():109061. PubMed ID: 35613674
[TBL] [Abstract][Full Text] [Related]
12. Trimethylamine-N-oxide (TMAO)-induced atherosclerosis is associated with bile acid metabolism.
Ding L; Chang M; Guo Y; Zhang L; Xue C; Yanagita T; Zhang T; Wang Y
Lipids Health Dis; 2018 Dec; 17(1):286. PubMed ID: 30567573
[TBL] [Abstract][Full Text] [Related]
13. Bile acid is a significant host factor shaping the gut microbiome of diet-induced obese mice.
Zheng X; Huang F; Zhao A; Lei S; Zhang Y; Xie G; Chen T; Qu C; Rajani C; Dong B; Li D; Jia W
BMC Biol; 2017 Dec; 15(1):120. PubMed ID: 29241453
[TBL] [Abstract][Full Text] [Related]
14. Dietary bile acids reduce liver lipid deposition via activating farnesoid X receptor, and improve gut health by regulating gut microbiota in Chinese perch (Siniperca chuatsi).
Zhang Y; Feng H; Liang XF; He S; Lan J; Li L
Fish Shellfish Immunol; 2022 Feb; 121():265-275. PubMed ID: 35026410
[TBL] [Abstract][Full Text] [Related]
15. Small molecule inhibition of gut microbial choline trimethylamine lyase activity alters host cholesterol and bile acid metabolism.
Pathak P; Helsley RN; Brown AL; Buffa JA; Choucair I; Nemet I; Gogonea CB; Gogonea V; Wang Z; Garcia-Garcia JC; Cai L; Temel R; Sangwan N; Hazen SL; Brown JM
Am J Physiol Heart Circ Physiol; 2020 Jun; 318(6):H1474-H1486. PubMed ID: 32330092
[TBL] [Abstract][Full Text] [Related]
16. Gut microbiota-bile acid-intestinal Farnesoid X receptor signaling axis orchestrates cadmium-induced liver injury.
Liu Y; Kang W; Liu S; Li J; Liu J; Chen X; Gan F; Huang K
Sci Total Environ; 2022 Nov; 849():157861. PubMed ID: 35934034
[TBL] [Abstract][Full Text] [Related]
17. Theabrownin from Pu-erh tea attenuates hypercholesterolemia via modulation of gut microbiota and bile acid metabolism.
Huang F; Zheng X; Ma X; Jiang R; Zhou W; Zhou S; Zhang Y; Lei S; Wang S; Kuang J; Han X; Wei M; You Y; Li M; Li Y; Liang D; Liu J; Chen T; Yan C; Wei R; Rajani C; Shen C; Xie G; Bian Z; Li H; Zhao A; Jia W
Nat Commun; 2019 Oct; 10(1):4971. PubMed ID: 31672964
[TBL] [Abstract][Full Text] [Related]
18. FXR agonist GW4064 improves liver and intestinal pathology and alters bile acid metabolism in rats undergoing small intestinal resection.
Cao Y; Xiao Y; Zhou K; Yan J; Wang P; Yan W; Cai W
Am J Physiol Gastrointest Liver Physiol; 2019 Aug; 317(2):G108-G115. PubMed ID: 30920307
[TBL] [Abstract][Full Text] [Related]
19. Crosstalk between Bile Acids and Gut Microbiota and Its Impact on Farnesoid X Receptor Signalling.
Wahlström A; Kovatcheva-Datchary P; Ståhlman M; Bäckhed F; Marschall HU
Dig Dis; 2017; 35(3):246-250. PubMed ID: 28249261
[TBL] [Abstract][Full Text] [Related]
20. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway.
Sun R; Yang N; Kong B; Cao B; Feng D; Yu X; Ge C; Huang J; Shen J; Wang P; Feng S; Fei F; Guo J; He J; Aa N; Chen Q; Pan Y; Schumacher JD; Yang CS; Guo GL; Aa J; Wang G
Mol Pharmacol; 2017 Feb; 91(2):110-122. PubMed ID: 27932556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
